Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Incannex Healthcare (IXHL) over the last 3 years, with Q4 2025 value amounting to -$3.7 million.

  • Incannex Healthcare's Net Cash Flow fell 14013.11% to -$3.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $67.0 million, marking a year-over-year increase of 66703.35%. This contributed to the annual value of $8.9 million for FY2025, which is 15504.9% up from last year.
  • As of Q4 2025, Incannex Healthcare's Net Cash Flow stood at -$3.7 million, which was down 14013.11% from $57.9 million recorded in Q3 2025.
  • Incannex Healthcare's Net Cash Flow's 5-year high stood at $57.9 million during Q3 2025, with a 5-year trough of -$6.0 million in Q3 2023.
  • For the 3-year period, Incannex Healthcare's Net Cash Flow averaged around $4.7 million, with its median value being -$2.2 million (2023).
  • Examining YoY changes over the last 5 years, Incannex Healthcare's Net Cash Flow showed a top increase of 262220.29% in 2025 and a maximum decrease of 14013.11% in 2025.
  • Over the past 3 years, Incannex Healthcare's Net Cash Flow (Quarter) stood at -$2.2 million in 2023, then rose by 29.46% to -$1.5 million in 2024, then plummeted by 140.13% to -$3.7 million in 2025.
  • Its Net Cash Flow was -$3.7 million in Q4 2025, compared to $57.9 million in Q3 2025 and $8.1 million in Q2 2025.